American Capital has sold Mirion Technologies, a provider of radiation detection, measurement, analysis and monitoring products and services to the nuclear power, medical, military and homeland security markets to Charterhouse Capital Partners for USD750 million.
Mirion was created in December 2005 through the merger of portfolio companies synOdys, Global Dosimetry Solutions (GDS) and Imaging and Sensing Technology (IST). Following the merger, the three companies were realigned into the current five business segments: the Sensing Systems Division, the Imaging Systems Division, the Radiation Monitoring Systems Division, the Dosimetry Services Division and the Health Physics Division. Headquartered in San Ramon, CA, Mirion has 13 facilities across North America, Europe and Asia and employs more than 1,000 people.
David Steinglass, Partner, American Capital Equity III, says: "This is the second exit for American Capital Equity III and represents a terrific outcome for all of our investors. We wish the management team all the best in their new partnership with Charterhouse."
"The sale of Mirion represents a successful conclusion to our long-standing relationship with American Capital and its affiliated funds," says Mirion Chairman & CEO Thomas Logan. "We are pleased to have created significant value for our shareholders and we are grateful for their support, partnership and camaraderie over the past decade."